Financial Performance - Huarong Chemical reported a total revenue of RMB 1.2 billion for the fiscal year 2022, representing a year-on-year increase of 15%[31]. - The company achieved a net profit of RMB 200 million in 2022, which is a 10% increase compared to the previous year[31]. - The company's operating revenue for 2022 was ¥1,135,008,258.39, representing a 76.14% increase compared to ¥644,384,542.46 in 2021[36]. - The net profit attributable to shareholders for 2022 was ¥122,148,212.10, a 19.90% increase from ¥101,876,191.46 in 2021[36]. - The total cash and cash equivalents increased by 56.96% to ¥276,443,750.95, driven by successful fundraising and bank loans[88]. - The company reported a net profit of CNY 44.52 million for the period, with a revenue of CNY 423.63 million, reflecting a significant contribution from its subsidiary, Huarong Chemical (Chengdu) Co., Ltd.[105]. - The company reported a revenue of 1.5 billion yuan for the fiscal year 2022, representing a year-over-year increase of 15%[130]. - The company has set a performance target for 2023, aiming for a revenue growth of 15% year-over-year[135]. Market Expansion and Strategy - Huarong Chemical plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share by 2025[31]. - The company is exploring potential mergers and acquisitions to enhance its product portfolio and market reach[31]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 500 million yuan allocated for potential deals[130]. - Huarong Chemical is focusing on expanding its market presence in Southeast Asia, with plans to increase exports by 20% in the next fiscal year[135]. - The company plans to enter three new provinces in China by the end of 2023, targeting a 5% market share in these regions[130]. Research and Development - The company is committed to enhancing its research and development capabilities for new products and technologies in the fine chemical sector[6]. - The company is investing RMB 100 million in R&D for new product development, focusing on eco-friendly chemical solutions[31]. - The company is focusing on R&D innovation, particularly in the development of G4 and G5 grade electronic hydrochloric acid and increasing production of electronic-grade potassium hydroxide and hydrochloric acid[109]. - The R&D budget for new product development has been increased by 25% in 2022, emphasizing innovation in chemical materials[135]. - The number of R&D personnel increased by 17.50% from 80 in 2021 to 94 in 2022, with a notable rise in the proportion of personnel holding bachelor's degrees to 70.27%[84]. Environmental Compliance and Sustainability - The company emphasizes compliance with environmental regulations, having reported no violations during the reporting period[10]. - Huarong Chemical is committed to sustainability, with plans to reduce carbon emissions by 15% over the next three years[31]. - The company has invested in advanced treatment facilities, such as the chlorine gas alkaline washing tower and the chlorine gas absorption tower, to ensure compliance with emission standards[167]. - Huarong Chemical's overall environmental management practices have resulted in no instances of exceeding discharge limits for key pollutants in the reporting period[166]. - The company has established emergency response plans for environmental incidents as per the regulations effective from September 28, 2010[163]. Operational Efficiency - The company has implemented new strategies to improve operational efficiency, aiming for a 5% reduction in production costs[31]. - The company is implementing new technologies to enhance operational efficiency, aiming for a 15% reduction in production costs by 2024[133]. - The production process is highly automated, with a continuous production model in place to ensure efficiency and quality control[53]. - The company has established a circular economy operation model, linking various production sectors and processes to optimize resource utilization[53]. Governance and Management - The company has established a comprehensive governance structure, ensuring clear responsibilities among the shareholders' meeting, board of directors, supervisory board, and senior management, with no significant deficiencies in governance[115]. - The company has conducted several shareholder meetings in 2022, with participation rates of 75.04% for the first extraordinary meeting, 75.01% for the annual meeting, and 75.12% for the third extraordinary meeting[119]. - The company’s board of directors includes experienced professionals with backgrounds in finance and management, enhancing its strategic direction[124]. - The company has established a performance-oriented compensation system to enhance employee motivation and align with market standards[149]. Financial Management and Fundraising - The company raised a total of RMB 966 million through the issuance of 12 million shares at RMB 8.05 per share, with a net amount of RMB 901.42 million after deducting issuance costs[97]. - The company has committed to using the raised funds in compliance with regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange[97]. - The company will enhance the management of raised funds to improve capital utilization efficiency[182]. - The company has established measures to ensure fair pricing in any necessary related party transactions[183]. Safety and Risk Management - The company acknowledges the risk of safety incidents during production due to operational errors or equipment failures[10]. - The company has a significant focus on safety, with multiple safety production licenses and hazardous chemical operation permits[61]. - The company organized emergency drills every six months and specialized drills quarterly as part of its emergency response plan[168]. Shareholder Relations and Commitments - The company has established a clear policy for reporting shareholdings and changes by its directors and senior management[180]. - The company will ensure compliance with the China Securities Regulatory Commission and Shenzhen Stock Exchange regulations regarding shareholding changes[181]. - The company has committed to transparency regarding any unfulfilled public commitments and will disclose relevant information in its periodic reports[183].

Financial Performance - The company's revenue for Q3 2022 reached ¥365,095,595.66, representing a 187.37% increase year-over-year[5]. - Net profit attributable to shareholders was ¥40,052,611.27, up 104.77% compared to the same period last year[5]. - Operating income for the year-to-date reached ¥801,715,694.16, an 80.69% increase compared to the same period last year[9]. - Total operating revenue for the current period reached ¥801,715,694.16, a significant increase from ¥443,689,774.48 in the previous period, representing an increase of approximately 80.7%[19]. - Net profit for the current period was ¥75,673,586.96, compared to ¥69,386,112.41 in the previous period, indicating an increase of approximately 9.3%[20]. - Basic earnings per share for the period was ¥0.0834, a 53.56% increase year-over-year[5]. - Basic and diluted earnings per share were both reported at ¥0.1577, down from ¥0.1927 in the previous period[20]. Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥2,159,715,602.97, reflecting a 175.44% increase from the previous year-end[5]. - Current assets amounted to CNY 1,877,991,507.93, up from CNY 524,332,157.59 at the start of the year, indicating a growth of about 258%[16]. - Total liabilities rose to CNY 552,377,982.14 from CNY 130,021,302.75, marking an increase of approximately 325%[17]. - The company's equity attributable to shareholders increased to CNY 1,607,337,620.83 from CNY 654,069,040.90, reflecting a growth of about 145%[17]. Cash Flow - Cash flow from operating activities generated a net amount of ¥131,748,918.63, a turnaround from a negative cash flow of ¥26,085,255.11 in the previous period[21]. - Cash inflow from investment activities totaled ¥2,035,236,249.61, significantly higher than ¥310,059,894.49 in the previous period[21]. - The company reported a net cash outflow from investment activities of ¥1,144,489,457.56, compared to a smaller outflow of ¥50,531,199.38 in the previous period[21]. - Cash flow from financing activities resulted in a net inflow of ¥1,017,183,756.24, contrasting with a net outflow of ¥10,015,000.00 in the previous period[22]. - The company’s cash and cash equivalents at the end of the period stood at ¥294,680,394.39, up from ¥19,321,302.64 at the end of the previous period[22]. Investments and Receivables - The company reported a significant increase in accounts receivable, which rose by 133.69% to ¥68,132,376.80 due to increased business volume[9]. - The company experienced a 341.81% increase in financing receivables, totaling ¥49,109,713.08, attributed to higher business activity[9]. - The company reported a 471.47% increase in investment income, amounting to ¥12,196,249.61, due to higher returns from structured deposits[9]. Borrowings and Financial Strategy - The company has seen a significant rise in short-term borrowings, which increased by 1,854.58% to ¥150,009,333.33, indicating a strategy to leverage for growth[9]. - Short-term borrowings surged to CNY 150,009,333.33, compared to CNY 7,674,748.24 at the beginning of the year, representing an increase of over 1,900%[17]. Other Financial Metrics - The total number of restricted shares at the end of the period was 360,000,000, with 7,322,657 shares released during the current period[13]. - The company plans to unlock 343,800,000 shares of restricted stock by March 22, 2025, as part of its initial public offering restrictions[13]. - The company has increased its prepayments to CNY 105,221,606.33 from CNY 21,958,564.31, showing a growth of approximately 378%[16]. - Inventory levels were reported at CNY 94,330,547.13, up from CNY 89,225,313.34, indicating a growth of approximately 6%[16]. - The company experienced a decrease in financial expenses, reporting a net financial income of ¥6,689,926.08 compared to an expense of ¥285,227.00 in the previous period[19].

证券代码：301256 证券简称：华融化学 公告编号：2022-044 华融化学股份有限公司 关于参加四川辖区上市公司 2022 年 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，华融化学股份有限公司（以下简称"公 司"）将参加由中国证券监督管理委员会四川监管局、四川省上市公司协会与深 圳市全景网络有限公司联合举办的"四川辖区上市公司 2022 年投资者网上集体 接待日"活动，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP, 参与本次互动交流，活动时间为 2022 年 9 月 16 日（周五）15:00-17:00。届时 公司董事长邵军先生，副总经理、董事会秘书、财务总监张炜先生将在线就公司 2022 年半年度业绩、经营状况、公司治理、风险防控、发展战略和可持续发展 等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与。 特此公告。 华融化学股份有限公 ...

Business Strategy and Market Focus - The company has implemented an innovative development strategy focusing on "potassium extension and chlorine transformation," aiming to increase the production and sales of high-value-added new products such as wet electronic chemicals and food additives [5]. - The company is focusing on expanding its market presence in high-end daily chemicals and food pharmaceuticals [5]. - The company is focusing on developing high-end, fine potassium and chlorine products for modern industries, including electronics and renewable energy [46]. - The company plans to continue expanding its market presence and invest in new product development [161]. Financial Performance - The company's operating revenue for the first half of 2022 was RMB 436,620,098.50, representing a 37.89% increase compared to RMB 316,642,018.14 in the same period last year [34]. - The net profit attributable to shareholders of the listed company decreased by 28.51% to RMB 35,620,975.69 from RMB 49,826,728.01 year-on-year [34]. - The net profit after deducting non-recurring gains and losses fell by 38.82% to RMB 26,322,603.75 compared to RMB 43,028,079.88 in the previous year [34]. - The company's total assets increased by 135.89% to RMB 1,849,566,837.39 from RMB 784,090,343.65 at the end of the previous year [34]. - The net assets attributable to shareholders of the listed company rose by 143.33% to RMB 1,591,517,001.06 from RMB 654,069,040.90 at the end of the previous year [34]. - The basic earnings per share decreased by 46.39% to RMB 0.0742 from RMB 0.1384 in the same period last year [34]. - The weighted average return on equity decreased to 5.30% from 8.62% year-on-year [34]. - The company reported a net cash flow from operating activities of RMB -82,014,522.82, a decline of 3.43% compared to RMB -79,294,439.85 in the previous year [34]. Cost and Pricing Challenges - The main profit source is potassium hydroxide, but the overall loss in chlorine products is attributed to a significant increase in hydrochloric acid sales and rising raw material costs, particularly potassium chloride [6][7]. - The company's potassium product costs increased by 59.50% year-on-year, with a gross margin of 21.66%, down 17.16% year-on-year [45]. - Operating costs increased by 62.78% to ¥372,220,104.83, primarily driven by rising procurement prices for potassium chloride and energy costs [55]. - The gross profit margin for potassium products decreased by 17.16% to 21.66%, while the gross profit margin for chlorine products increased by 78.24% to -22.41% [57]. Supply Chain and Operational Risks - The company faces risks related to supplier dependence, as potassium chloride is a scarce resource in China, with domestic production only meeting about 50% of demand [8]. - The international potassium chloride supply has been severely imbalanced due to the Russia-Ukraine conflict, leading to a 31.7% increase in import prices [43]. - The domestic industrial potassium chloride supply has been extremely tight, with nearly all domestic production allocated to agricultural use [43]. - The company expanded its procurement channels by adding several foreign potassium chloride agents to ensure supply [43]. - The production process involves hazardous chemicals, and any accidents during transportation could affect sales performance and operational stability [11]. Environmental Compliance and Sustainability - The company has reported compliance with environmental standards during the reporting period, but risks remain regarding potential pollution incidents [9]. - The company has achieved compliance with environmental regulations, with pollutant emissions within legal limits and proper disposal of solid and hazardous waste [92]. - The company has constructed and operates pollution prevention facilities in accordance with relevant requirements, ensuring stable operation [90]. - The company has developed an emergency response plan for environmental incidents, conducting regular drills to ensure preparedness [88]. Governance and Management - The company has established a governance structure with a clear delineation of rights and responsibilities among shareholders, the board of directors, and management, revising multiple internal regulations in April 2022 to comply with the latest regulatory requirements [91]. - The company has appointed new executives, including a Chief Digital Officer and a new Deputy General Manager, as part of its management restructuring [83]. - The company has not implemented any employee stock ownership plans or other incentive measures during the reporting period [85]. Investment and Fundraising - The total amount of funds raised by the company is RMB 966.00 million, with a net amount of RMB 901.42 million after deducting issuance costs [65]. - The company has committed to invest RMB 49.50 million in various projects, with a cumulative investment of RMB 28.12 million, achieving 84% of the planned investment [68]. - The company plans to use RMB 12.00 million of the excess raised funds to permanently supplement working capital [68]. - The company has allocated RMB 78.00 million of idle raised funds for cash management purposes [69]. Shareholder Information - The largest shareholder, New Hope Group, holds 71.63% of the company's shares, totaling 343.8 million shares [121]. - The company has a total of 40,884 shareholders as of the reporting period [121]. - The company reported a total of 360 million restricted shares, representing 75% of the total shares [117]. - The company’s share capital structure includes both restricted and unrestricted shares, with 120 million unrestricted shares issued [118]. Financial Reporting and Audit - The half-year financial report was not audited, which may impact the reliability of the financial data presented [133]. - The company’s financial statements are prepared based on the assumption of going concern, ensuring ongoing operational viability [170]. - The company’s financial report was approved by the board of directors on July 27, 2022, ensuring governance compliance [167].

Financial Performance - The company's revenue for Q1 2022 was ¥161,564,904.21, representing an increase of 11.61% compared to ¥144,758,061.73 in the same period last year[4] - Net profit attributable to shareholders decreased by 75.20% to ¥6,298,759.91 from ¥25,397,680.57 year-on-year[4] - The company's basic earnings per share decreased by 71.43% to ¥0.02 from ¥0.07 in the same period last year[4] - The operating profit for Q1 2022 was CNY 7,446,179.80, down 75.2% from CNY 29,978,609.81 in the previous year[21] - The net profit for Q1 2022 was CNY 6,298,759.91, a decrease of 75.2% from CNY 25,397,680.57 in Q1 2021[21] Cash Flow - The net cash flow from operating activities improved by 34.67%, reaching -¥36,640,674.50 compared to -¥56,085,877.41 in the previous year[4] - Cash inflow from operating activities in Q1 2022 was CNY 179,984,641.31, significantly higher than CNY 87,101,283.60 in the same period last year[23] - The cash outflow from operating activities amounted to 216,625,315.81 CNY, an increase from 143,187,161.01 CNY year-over-year[25] - The ending balance of cash and cash equivalents was 1,009,330,737.93 CNY, up from 125,419,600.77 CNY year-over-year[26] - The company reported a total cash outflow from financing activities of 262,608.33 CNY, compared to 10,015,000.00 CNY in the previous year[25] Assets and Liabilities - Total assets increased by 122.15% to ¥1,741,864,954.53 from ¥784,090,343.65 at the end of the previous year[4] - The total liabilities as of Q1 2022 amounted to CNY 179,496,929.37, compared to CNY 130,021,302.75 in Q1 2021, reflecting a 38.0% increase[20] - The company's equity attributable to shareholders rose by 138.87% to ¥1,562,368,025.16 from ¥654,069,040.90 at the end of the previous year[4] Operating Costs and Expenses - The gross profit margin was impacted by rising raw material costs, particularly potassium chloride, leading to a 41% increase in operating costs to ¥142,865,303.12 from ¥101,391,449.60[8] - The total operating costs for Q1 2022 were CNY 154,953,925.02, up 31.4% from CNY 117,949,815.69 in Q1 2021[20] - Research and development expenses increased by 31% to ¥2,448,279.85 from ¥1,874,167.19 year-on-year[8] - Research and development expenses for Q1 2022 were CNY 2,448,279.85, an increase from CNY 1,874,167.19 in Q1 2021[20] Borrowings and Financing - The company reported a significant increase in short-term borrowings by 169% to ¥20,670,866.66 from ¥7,674,748.24 year-on-year[7] - Short-term borrowings increased to approximately 20.67 million RMB from 7.67 million RMB at the beginning of the year[17] - Total cash inflow from financing activities reached 921,040,401.00 CNY, with a net cash flow of 920,777,792.67 CNY, a significant increase from -10,015,000.00 CNY in the previous year[25] Market and Strategic Focus - The company plans to increase export business due to high overseas demand for potassium hydroxide, with significant growth in export orders expected[14] - The company aims to enhance the supply of potassium fertilizers, particularly during the spring planting season, leveraging its position in Sichuan[14] - The company is focusing on maintaining product quality to meet the demands of high-end clients in various sectors[14] - The company is enhancing its self-operated hazardous chemical transportation capacity to mitigate logistics challenges[14] Government Support - The company received government subsidies amounting to ¥464,504.95, a decrease of 86% compared to the previous year[8] Foreign Exchange Impact - The company experienced a foreign exchange impact of -79,673.99 CNY on cash and cash equivalents[25] Audit Status - The company did not conduct an audit for the first quarter report[27]

Financial Performance - The company's operating revenue for 2021 was ¥644,384,542.46, a decrease of 31.89% compared to ¥946,032,673.09 in 2020[28]. - The net profit attributable to shareholders for 2021 was ¥101,876,191.46, down 1.37% from ¥103,290,722.87 in 2020[28]. - The net cash flow from operating activities decreased by 50.82% to ¥36,180,512.53 in 2021 from ¥73,574,577.78 in 2020[28]. - The total assets at the end of 2021 increased by 10.82% to ¥784,090,343.65 from ¥707,533,321.04 at the end of 2020[28]. - The net assets attributable to shareholders rose by 18.39% to ¥654,069,040.90 at the end of 2021 compared to ¥552,488,216.14 at the end of 2020[28]. - The basic earnings per share for 2021 was ¥0.28, a decrease of 3.45% from ¥0.29 in 2020[28]. - The company reported a total of ¥15,354,920.57 in non-recurring gains and losses for 2021, compared to ¥2,851,028.32 in 2020[34]. - The company experienced a net profit of ¥32,490,079.05 in Q4 2021, which was the highest quarterly profit for the year[31]. - The company’s weighted average return on equity for 2021 was 16.89%, down from 21.04% in 2020[28]. - The company reported a net profit attributable to shareholders of CNY 10.19 million, a slight decrease of 1.37% year-on-year, indicating stable profitability despite revenue decline[60]. Market and Product Development - The company implemented an innovative development strategy focusing on "potassium extension and chlorine transformation," aiming to enhance the production and sales of high-value-added products such as wet electronic chemicals and food additives[6]. - The company plans to continue focusing on market expansion and new product development in the upcoming year[38]. - The domestic demand for potassium hydroxide increased steadily in 2021, with total consumption rising compared to 2020, driven by traditional industries such as fertilizers and pharmaceuticals[40]. - The production of electronic-grade and photovoltaic-grade fine potassium products is a key focus, catering to modern industries such as electronics and new energy[42]. - The company is actively adjusting its product and channel structure to promote high-end markets more aggressively[40]. - The company is developing electronic-grade potassium hydroxide with sodium content below 50ppm, which has passed semiconductor customer verification[49]. - The company is committed to advancing R&D for G4 and G5 grade electronic hydrochloric acid, as part of its innovation strategy[95]. - The company is focusing on wet electronic chemicals as a key product for future development, driven by the rising demand in semiconductor, solar photovoltaic, and display panel industries[95]. Supply Chain and Raw Material Costs - The main profit source for the company is potassium hydroxide, with a significant loss in hydrochloric acid products due to increased costs and lower sales of high-grade hydrochloric acid[7][8]. - The company faces risks related to supplier dependence, particularly on potassium chloride, which is scarce and primarily sourced from a few state-owned enterprises[9]. - The price of potassium chloride, a key raw material for potassium hydroxide production, surged by over 90% during the reporting period[40]. - The average procurement price of potassium chloride increased by 36.43% year-on-year due to the impact of the COVID-19 pandemic and supply chain disruptions[49]. - The cost of raw materials, particularly potassium chloride, increased by over 90%, leading to a corresponding price adjustment for products[61]. Research and Development - The company has applied for 13 patents and has 9 patents under review related to potassium hydroxide production technology[49]. - The company has invested in R&D, establishing a provincial engineering technology research center for potassium hydroxide preparation and comprehensive application[58]. - Research and development expenses amounted to CNY 10,096,784.10, an increase of 12.50% compared to CNY 8,974,627.58 in 2020[73]. - The number of R&D personnel increased by 26.98% from 63 in 2020 to 80 in 2021, with R&D personnel now accounting for 13.61% of the total workforce[76]. - The R&D investment as a percentage of operating income rose to 1.57% in 2021 from 1.02% in 2020[76]. Operational Efficiency and Capacity - The company employs a continuous production model with high automation, ensuring efficient production processes[47]. - The designed capacity for potassium hydroxide is 90,000 tons with a utilization rate of 90.92%[50]. - The designed capacity for hydrochloric acid is 160,000 tons with a utilization rate of 76.30%[50]. - The designed capacity for sodium hypochlorite is 40,000 tons with a utilization rate of 165.74%[50]. - The company has a current production capacity of 40,000 tons per year for sodium hypochlorite, with plans to enhance both production volume and quality following the completion of fundraising projects[41]. Financial Management and Governance - The company reported a cash dividend of 0.50 RMB per 10 shares (including tax) based on a total of 480,000,000 shares, with no bonus shares issued[14]. - The total distributable profit for the year was 174,568,866.73 yuan, with no retained earnings distributed for future years[148]. - The company has established a governance structure that clearly defines the rights and responsibilities among shareholders, the board, and management[162]. - The company has a robust governance structure in place, complying with relevant laws and regulations, ensuring clear responsibilities among its governing bodies[100]. - The company has established a complete and independent business system, ensuring independence from its controlling shareholders in operations, assets, and finances[101]. Environmental and Social Responsibility - The company emphasizes the importance of environmental safety and has adopted a circular economy model to enhance its market competitiveness[95]. - Carbon emissions decreased by 25% year-on-year due to the suspension of polyvinyl chloride resin production at the end of 2020[161]. - The company has implemented pollution prevention facilities and established management systems to ensure stable operation[158]. - The company donated nearly 100,000 yuan in disinfectants to support flood relief efforts during the 2021 Henan floods[162]. Future Outlook - The company provided a future outlook with a revenue guidance of 1.5 billion RMB for 2022, indicating a projected growth of 25%[108]. - The company plans to significantly increase the sales of potassium hydroxide products in the phosphate potassium salt market, especially during the spring fertilization peak season[95]. - The company aims to enhance the proportion of high-end products, ensuring that sales in niche markets such as new materials, pharmaceuticals, and photovoltaic sectors remain unaffected[95]. - The company is expanding its market presence in Southeast Asia, targeting a 20% increase in sales from this region by 2023[110].